Cargando…

Validación de la metodología para cuantificar el fluconazol y sus impurezas orgánicas en materia prima por cromatografía líquida de alta resolución

INTRODUCTION. The real laboratory conditions of each country, including climate, can affect the method's efficiency in analyzing a pharmacological substance. Thus, it is necessary to validate the process according to the corresponding guidelines and optimize it to ensure success and confidence...

Descripción completa

Detalles Bibliográficos
Autores principales: Castillo, James Alexander, Afanasjeva, Natalia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Instituto Nacional de Salud 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10588965/
https://www.ncbi.nlm.nih.gov/pubmed/37721917
http://dx.doi.org/10.7705/biomedica.6850
_version_ 1785123693319421952
author Castillo, James Alexander
Afanasjeva, Natalia
author_facet Castillo, James Alexander
Afanasjeva, Natalia
author_sort Castillo, James Alexander
collection PubMed
description INTRODUCTION. The real laboratory conditions of each country, including climate, can affect the method's efficiency in analyzing a pharmacological substance. Thus, it is necessary to validate the process according to the corresponding guidelines and optimize it to ensure success and confidence in the results. OBJECTIVE. The objective was to validate a methodology for fluconazole and its organic impurities quantification in raw material using high-performance liquid chromatography, with a diode array detector, under tropical climate conditions, and complying with all regulatory requirements. MATERIALS AND METHODS. We performed pre-validation tests of the method consisting of system adequacy, filters study, quantification limit, absence of systematic error, forced degradation studies, and solutions stability. In addition, we validated the specificity, linearity, accuracy, precision, and robustness of the system. RESULTS. Separation of the degradation products from the analyte peaks allowed the achievement of the method's spectral purity. The solution's stability was not affected during the evaluated time (24 hours) at room temperature and under refrigeration. Linearity resulted in correlation coefficients greater than or equal to 0.999 for the evaluation and greater than or equal to 0.997 for impurities. We obtained a fluconazole recovery varying from 98 to 102% with an accuracy between 80 to 120% for impurities detection. The repeatability and reproducibility factor did not exceed a relative standard deviation of 2.0% for the evaluation and of 5.0% for the impurities, demonstrating the adequate robustness of the method. In addition, a short analysis execution time allowed the quick determination of the raw material quality. CONCLUSION. We demonstrated that the fluconazole quantification method validated by high-performance liquid chromatography is sufficiently selective, precise, exact, linear, and robust to generate accurate analytical results under real conditions, including the tropical climate of Colombia.
format Online
Article
Text
id pubmed-10588965
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Instituto Nacional de Salud
record_format MEDLINE/PubMed
spelling pubmed-105889652023-10-21 Validación de la metodología para cuantificar el fluconazol y sus impurezas orgánicas en materia prima por cromatografía líquida de alta resolución Castillo, James Alexander Afanasjeva, Natalia Biomedica Artículo Original INTRODUCTION. The real laboratory conditions of each country, including climate, can affect the method's efficiency in analyzing a pharmacological substance. Thus, it is necessary to validate the process according to the corresponding guidelines and optimize it to ensure success and confidence in the results. OBJECTIVE. The objective was to validate a methodology for fluconazole and its organic impurities quantification in raw material using high-performance liquid chromatography, with a diode array detector, under tropical climate conditions, and complying with all regulatory requirements. MATERIALS AND METHODS. We performed pre-validation tests of the method consisting of system adequacy, filters study, quantification limit, absence of systematic error, forced degradation studies, and solutions stability. In addition, we validated the specificity, linearity, accuracy, precision, and robustness of the system. RESULTS. Separation of the degradation products from the analyte peaks allowed the achievement of the method's spectral purity. The solution's stability was not affected during the evaluated time (24 hours) at room temperature and under refrigeration. Linearity resulted in correlation coefficients greater than or equal to 0.999 for the evaluation and greater than or equal to 0.997 for impurities. We obtained a fluconazole recovery varying from 98 to 102% with an accuracy between 80 to 120% for impurities detection. The repeatability and reproducibility factor did not exceed a relative standard deviation of 2.0% for the evaluation and of 5.0% for the impurities, demonstrating the adequate robustness of the method. In addition, a short analysis execution time allowed the quick determination of the raw material quality. CONCLUSION. We demonstrated that the fluconazole quantification method validated by high-performance liquid chromatography is sufficiently selective, precise, exact, linear, and robust to generate accurate analytical results under real conditions, including the tropical climate of Colombia. Instituto Nacional de Salud 2023-08-31 /pmc/articles/PMC10588965/ /pubmed/37721917 http://dx.doi.org/10.7705/biomedica.6850 Text en https://creativecommons.org/licenses/by/4.0/Este es un artículo publicado en acceso abierto bajo una licencia Creative Commons
spellingShingle Artículo Original
Castillo, James Alexander
Afanasjeva, Natalia
Validación de la metodología para cuantificar el fluconazol y sus impurezas orgánicas en materia prima por cromatografía líquida de alta resolución
title Validación de la metodología para cuantificar el fluconazol y sus impurezas orgánicas en materia prima por cromatografía líquida de alta resolución
title_full Validación de la metodología para cuantificar el fluconazol y sus impurezas orgánicas en materia prima por cromatografía líquida de alta resolución
title_fullStr Validación de la metodología para cuantificar el fluconazol y sus impurezas orgánicas en materia prima por cromatografía líquida de alta resolución
title_full_unstemmed Validación de la metodología para cuantificar el fluconazol y sus impurezas orgánicas en materia prima por cromatografía líquida de alta resolución
title_short Validación de la metodología para cuantificar el fluconazol y sus impurezas orgánicas en materia prima por cromatografía líquida de alta resolución
title_sort validación de la metodología para cuantificar el fluconazol y sus impurezas orgánicas en materia prima por cromatografía líquida de alta resolución
topic Artículo Original
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10588965/
https://www.ncbi.nlm.nih.gov/pubmed/37721917
http://dx.doi.org/10.7705/biomedica.6850
work_keys_str_mv AT castillojamesalexander validaciondelametodologiaparacuantificarelfluconazolysusimpurezasorganicasenmateriaprimaporcromatografialiquidadealtaresolucion
AT afanasjevanatalia validaciondelametodologiaparacuantificarelfluconazolysusimpurezasorganicasenmateriaprimaporcromatografialiquidadealtaresolucion